Literature DB >> 12100203

Response of livedoid vasculitis to intravenous immunoglobulin.

F E Ravat1, A V Evans, R Russell-Jones.   

Abstract

Livedoid vasculitis is a chronic condition characterized by recurrent painful ulceration of the lower limbs, which heals to leave atrophie blanche surrounded by hyperpigmentation and telangiectasia. We report two patients with livedoid vasculitis who, after failure of conventional therapies, responded to intravenous immunoglobulin (IVIg). There was healing of areas of active ulceration and improvement of erythema, swelling and pain. IVIg has been used successfully to treat a variety of vasculitic disorders and appears to be well tolerated. We suggest that this treatment is offered to patients who have livedoid vasculitis that is unresponsive to other therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100203     DOI: 10.1046/j.1365-2133.2002.04755.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

Review 1.  Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.

Authors:  Andreas Steinbrecher; Peter Berlit
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 2.  Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review.

Authors:  Yimeng Gao; Hongzhong Jin
Journal:  Ther Adv Chronic Dis       Date:  2022-05-22       Impact factor: 4.970

3.  Large leg ulcers due to autoimmune diseases.

Authors:  Alexander P Rozin; Dana Egozi; Yehuda Ramon; Kohava Toledano; Yolanda Braun-Moscovici; Doron Markovits; Daniel Schapira; Reuven Bergman; Yehuda Melamed; Yehuda Ullman; Alexandra Balbir-Gurman
Journal:  Med Sci Monit       Date:  2011-01

Review 4.  Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Authors:  Asli Bilgic; Salih Ozcobanoglu; Burcin Cansu Bozca; Erkan Alpsoy
Journal:  Int J Womens Dermatol       Date:  2021-09-02

5.  Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin.

Authors:  Katsunobu Yoshioka; Chiharu Tateishi; Hiromi Kato; Ko-Ron Chen
Journal:  Clin Case Rep       Date:  2018-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.